MENU
ADAP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Adaptimmune Therapeutics (ADAP) Ownership - Who owns Adaptimmune Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
60 Jubilee Avenue
Phone
+44 1235430000
Employees
449
Web
https://www.adaptimmune.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
151.2M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
2.32
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
0.59 USD as % of share price
Fundamentals
ADAP
Capitalization
151M
P/E Ratio
N/A
Risk (Beta)
2.32
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.59%
Revenue
N/A
ROE
N/A
Book Value
N/A
P/B Ratio
1.57
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
N/A
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
154M
Shares Outstanding - Current
256M
Total Liabilities
N/A
Total Volume MTD
N/A
Value
1
Gain YTD
-25.448
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of vaccines and cancer immunotherapy products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
60 Jubilee Avenue
Phone
+44 1235430000
Employees
449
Web
https://www.adaptimmune.com